Baxter (NYSE:BAX) today announced the launch of two updates for its Sharesource remote patient monitoring platform designed to monitor home peritoneal dialysis patients including the addition of a new modeling software tool and improvements to the clinical portal.
The Deerfield, Ill.-based company announced the updates at the 55th Congress of the European Renal Association and European Dialysis and Transplant Association meeting this week.
Baxter said that the first of its updates introduced the new Sharesource Adequest kinetic modeling software tool designed for direct integration into the platform to allow for improved modeling regimens for nephrologists and nurses. The addition allows for the identification of peritoneal membrane characteristics, the calculation and prediction of PD adequacy measures and the creation of APD and CAPD prescriptions.
The software suite’s clinical portal also received an update allowing the system to be used with Baxter’s Homechoice Claria APD system, and provides clarified data for ultrafiltration.
“We designed Sharesource to help transform and simplify home renal care, so more patients can access and stay on PD longer with confidence and fewer complications. We are committed to both generating clinical evidence to support the best real-world use of the platform, and to making continual improvements to the platform to ensure optimum value for healthcare providers and patients,” renal care biz GM Laura Angelini said in a press release.
Earlier this month Baxter said it inked a partnership deal with the International Society of Nephrology looking to advance awareness and therapy for patients with chronic kidney disease, primarily in low and middle-income countries where the disease is growing the fastest.
